Surgical Protocol Shows Promise as a New Standard of Care for Oncology Surgery
Implementation of the ERAS protocol has a dramatic effect on outcomes for patients undergoing prostate or renal cancer surgery.
Kidney Cancer
Kidney Cancer News & Features
A Case of Treatment-Related Heart Failure With Cabozantinib for Advanced Renal Cell Carcinoma
Case report illustrates the link between cabozantinib therapy and cardiomyopathy.
Extra Weight in Adolescence Tied to Later Risk for Renal Cancer
Among Swedish men, overweight or obesity during adolescence was associated with a higher risk for renal cell carcinoma.
Robotic Tumor Enucleation Appears Safe for Sporadic Renal Cell Carcinoma
The use of robotic tumor enucleation conferred favorable long-term surgical margins and local recurrence rates in patients with sporadic renal cell carcinoma (RCC), according to the results of a single-center Italian study.1 The findings were published online September 27, 2018, in Urologic Oncology. Patients undergoing robotic tumor enucleation with no ablation of the tumor bed…
Microwave Ablation for Early-Stage Renal Tumors
Percutaneous microwave ablation (MWA) is a promising treatment strategy for patients with cT1-stage renal tumors, but more research into patient risk stratification and selection is needed.
Kidney Cancer Clinical Trials
Clinical Trial: Phase II Study of Vandetanib in Individuals With Kidney Cancer
Clinical Trial: Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME)
Clinical Trial: Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer (CA9CRM)
Clinical Trial: Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC) (ADAPT)
Clinical Trials: Interleukin-2 in Metastatic Kidney Cancer
Want to read more?
Please login or register first to view this content.
Next post in Kidney Cancer
